Poster of the K-Beauty Pop-Up in Paris featuring Dr.Gentle | Photo provided by LUNACELL
Dermatology-based derma cosmetic brand Dr.Gentle participated in Cosmetic 360 2025, held from October 15 to 16 at the Carrousel du Louvre in Paris, marking its full-scale entry into the European market.
Following the exhibition, Dr.Gentle held a pop-up store in Paris’s Saint-Honoré district from October 17 to 23, allowing local consumers to experience its products firsthand and further strengthening its position as a leading K-beauty derma brand.
The event was part of the “2025 Global Showroom (France)” program organized by the Korea Small Enterprise and Market Service (SEMAS). With government support, Dr. Gentle carried out various promotional activities, including hosting a local pop-up store, holding buyer meetings, collaborating with influencers, and hosting online special exhibitions.
Dr.Gentle is operated by LUNACELL LNC, a biotech-based beauty company established in 2023. The company integrates single-cell analysis solutions with skin science to develop innovations that promote both health and beauty.
The Cosmetic 360 exhibition, hosted by Cosmetic Valley, Europe’s largest cosmetics industry cluster, is recognized as a premier business platform that brings together global buyers, research institutions, and innovative startups. Dr.Gentle presented its signature products, including CICA Cooling Soothing Gel and CICA Cooling Sun Serum SPF50+ PA++++, both developed as low-irritant derma cosmetics based on clinical data from Korean burn specialty hospitals.
According to local manager Éliane Maroco, “Visitors were especially impressed by the light and refreshing texture, cooling sensation, and the fact that Dr.Gentle’s products are backed by medical research. The brand’s scientifically formulated soothing and moisturizing effects have strong potential in the French market.”
Building on the event’s success, LUNACELL plans to expand B2B partnerships with buyers in France and across Europe while strengthening its distribution through global online platforms. The company also aims to launch a new line of microbiome-based creams and ampoules next year to complete its Europe-focused product portfolio.
